Skip to main content
David Charytan, MD, Nephrology, New York, NY, NYU Langone Hospitals

DavidMCharytanMDMSc

Nephrology New York, NY

Associate Professor of Medicine

Dr. Charytan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Charytan's full profile

Already have an account?

Education & Training

  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterFellowship, Nephrology, 2001 - 2004
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1998 - 2001
  • New York University School of Medicine
    New York University School of MedicineClass of 1998

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2018 - 2025
  • MA State Medical License
    MA State Medical License 2001 - 2022
  • FL State Medical License
    FL State Medical License 2014 - 2016
  • American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Association Between Early Treatment with Tocilizumab and Mortality Among Critically Ill Patients with COVID-19  
    Kusum S Mathews, Michal L Melamed, Samantha K Brenner, Amanda Leonberg-Yoo, Edward J Schenck, Jared Radbel, Jochen Reiser, Anip Bansal, Diana Finkel, Mary Mallappallil..., JAMA Internal Medicine
  • Nephrology and COVID-19  
    Wolfgang C Winkelmayer, Pascale Khairallah, David M Charytan, JAMA
  • Safety and Cardiovascular Efficacy of Spironolactone in Dialysis-Dependent ESRD (SPin-D): A Randomized, Placebo-Controlled, Multiple Dosage Trial  
    David M Charytan, Jonathan Himmelfarb, Adriana M Hung, Rajnish Mehrotra, Shailendra Sharma, Daniel E Weiner, Alan S Kliger, Laura M Dember, Kidney International
  • Join now to see all

Authored Content

  • The Authors ReplyJuly 2018

Press Mentions

  • How Would Eliminating Race-Based Adjustments in Estimates of Kidney Function Impact Clinical Trials?
    How Would Eliminating Race-Based Adjustments in Estimates of Kidney Function Impact Clinical Trials?January 21st, 2022
  • Is “Patient Activation Measure” Relevant for Adults on Dialysis?
    Is “Patient Activation Measure” Relevant for Adults on Dialysis?August 30th, 2021
  • Mortality & Progression to ESKD After Heart Surgeries in Patients with CKD
    Mortality & Progression to ESKD After Heart Surgeries in Patients with CKDAugust 16th, 2021
  • Join now to see all

Other Languages

  • Hebrew

Hospital Affiliations